A PET study following treatment with a pharmacological stressor, FG7142, in conscious rhesus monkeys

Brain Research

Volumn 980, Issue 2, 2003, Pages 275-280

  Takamatsu, Hiroyuki ^a,b   Noda, Akihiro ^a,b   Kurumaji, Akeo ^c   Murakami, Yoshihiro ^a,b   Tatsumi, Mitsuyoshi ^a   Ichise, Rikiya ^a   Nishimura, Shintaro ^a,b  

^a The Medical and Pharmacological Research Center Foundation   (Japan)

^b ASTELLAS PHARMA INC   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

FG7142; Monkey; Positron emission tomography; Stress

Indexed keywords

BENZODIAZEPINE RECEPTOR INVERSE STIMULATING AGENT; HYDROCORTISONE; N METHYL BETA CARBOLINE 3 CARBOXAMIDE; PROLACTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY DISORDER; ARTICLE; BRAIN BLOOD FLOW; BRAIN METABOLISM; CONCENTRATION RESPONSE; CONSCIOUSNESS; DATA ANALYSIS; GLUCOSE METABOLISM; HYDROCORTISONE BLOOD LEVEL; MALE; NONHUMAN; PHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RHESUS MONKEY; STATISTICAL SIGNIFICANCE; STRESS; THALAMUS;

EID: 0037627879     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(03)02987-1     Document Type: Article

References (35)

1. Abercrombie E.D., Keefe K.A., DiFrischia D.S., Zigmond M.J. Differential effect of stress on in vivo dopamine release in striatum, nucleus accumbens, and medial frontal cortex. J. Neurochem. 52:1989;1655-1658.
2. Ableitner A., Herz A. Changes in local cerebral glucose utilization induced by the beta-carbolines FG7142 and DMCM reveal brain structures involved in the control of anxiety and seizure activity. J. Neurosci. 7:1987;1047-1055.
3. Arnsten A.F., Murphy B., Merchant K. The selective dopamine D4 receptor antagonist, PNU-101387G, prevents stress-induced cognitive deficits in monkeys. Neuropsychopharmacology. 23:2000;405-410.
4. Birnbaum S.G., Podell D.M., Arnsten A.F. Noradrenergic alpha-2 receptor agonists reverse working memory deficits induced by the anxiogenic drug, FG7142, in rats. Pharmacol. Biochem. Behav. 67:2000;397-403.
5. Braestrup C., Nielsen M. Anxiety. Lancet. 2:1982;1030-1034.
6. Costall B., Jones B.J., Kelly M.E., Naylor R.J., Tomkins D.M. Exploration of mice in a black and white test box: validation as a model of anxiety. Pharmacol. Biochem. Behav. 32:1989;777-785.
7. Crawley J.N., Ninan P.T., Pickar D., Chrousos G.P., Linnoila M., Skolnick P., Paul S.M. Neuropharmacological antagonism of the beta-carboline-induced 'anxiety' response in rhesus monkeys. J. Neurosci. 5:1985;477-485.
8. Cross D.J., Minoshima S., Nishimura S., Noda A., Tsukada H., Kuhl D.E. Three-dimensional stereotactic surface projection analysis of macaque brain PET: development and initial applications. J. Nucl. Med. 41:2000;1879-1887.
9. Dazzi L., Spiga F., Pira L., Ladu S., Vacca G., Rivano A., Jentsch J.D., Biggio G. Inhibition of stress- or anxiogenic-drug-induced increases in dopamine release in the rat prefrontal cortex by long-term treatment with antidepressant drugs. J. Neurochem. 76:2001;1212-1220.
10. Deutch A.Y., Roth R.H. The determinants of stress-induced activation of the prefrontal cortical dopamine system. Prog. Brain Res. 85:1990;367-403.
11. Dorow R., Horowski R., Paschelke G., Amin M. Severe anxiety induced by FG7142, a beta-carboline ligand for benzodiazepine receptors. Lancet. 2:1983;98-99.
12. Ginsberg M.D., Howard B.E., Hassel W.R. Emission tomographic measurement of local cerebral blood flow in humans by an in vivo autoradiographic strategy. Ann. Neurol. 15:1984;S12-18.
13. Gur R.C., Gur R.E., Resnick S.M., Skolnick B.E., Alavi A., Reivich M. The effect of anxiety on cortical cerebral blood flow and metabolism. J. Cereb. Blood Flow Metab. 7:1987;173-177.
14. 2(15)O. I. Theory and error analysis. J. Nucl. Med. 24:1983;782-789.
15. Imperato A., Puglisi-Allegra S., Casolini P., Angelucci L. Changes in brain dopamine and acetylcholine release during and following stress are independent of the pituitary-adrenocortical axis. Brain Res. 538:1991;111-117.
16. Inglis F.M., Moghaddam B. Dopaminergic innervation of the amygdala is highly responsive to stress. J. Neurochem. 72:1999;1088-1094.
17. Martin I.L. The benzodiazepines and their receptors: 25 years of progress. Neuropharmacology. 26:1987;957-970.
18. Murphy B.L., Arnsten A.F., Goldman-Rakic P.S., Roth R.H. Increased dopamine turnover in the prefrontal cortex impairs spatial working memory performance in rats and monkeys. Proc. Natl. Acad. Sci. USA. 93:1996;1325-1329.
19. Murphy B.L., Arnsten A.F., Jentsch J.D., Roth R.H. Dopamine and spatial working memory in rats and monkeys: pharmacological reversal of stress-induced impairment. J. Neurosci. 16:1996;7768-7775.
20. Murphy B.L., Roth R.H., Arnsten A.F. Clozapine reverses the spatial working memory deficits induced by FG7142 in monkeys. Neuropsychopharmacology. 16:1997;433-437.
21. Noda A., Ohba H., Kakiuchi T., Futatsubashi M., Tsukada H., Nishimura S. Age-related changes in cerebral blood flow and glucose metabolism in conscious rhesus monkeys. Brain Res. 936:2002;76-81.
22. Noda A., Takamatsu H., Murakami Y., Yajima K., Tatsumi M., Ichise R., Nishimura S. Measurement of brain concentration of FK960 for development of a novel antidementia drug: a PET study in conscious rhesus monkeys. J. Nucl. Med. 44:2003;105-108.
23. Phelps M.E., Huang S.C., Hoffman E.J., Selin C., Sokoloff L., Kuhl D.E. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method. Ann. Neurol. 6:1979;371-388.
24. 2(15)O. II. Implementation and validation. J. Nucl. Med. 24:1983;790-798.
25. Reivich M., Alavi A., Wolf A., Fowler J., Russell J., Arnett C., MacGregor R.R., Shiue C.Y., Atkins H., Anand A., et al. Glucose metabolic rate kinetic model parameter determination in humans: the lumped constants and rate constants for [18F]fluorodeoxyglucose and [11C]deoxyglucose. J. Cereb. Blood Flow Metab. 5:1985;179-192.
26. Sokoloff L., Reivich M., Kennedy C., Des Rosiers M.H., Patlak C.S., Pettigrew K.D., Sakurada O., Shinohara M. The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J. Neurochem. 28:1977;897-916.
27. Stout J.C., Weiss J.M. An animal model for measuring behavioral responses to anxiogenic and anxiolytic manipulations. Pharmacol. Biochem. Behav. 47:1994;459-465.
28. Takeda H., Tsuji M., Matsumiya T. Changes in head-dipping behavior in the hole-board test reflect the anxiogenic and/or anxiolytic state in mice. Eur. J. Pharmacol. 350:1998;21-29.
29. Tallman J.F., Gallager D.W. The GABA-ergic system: a locus of benzodiazepine action. Annu. Rev. Neurosci. 8:1985;21-44.
30. Tam S.Y., Roth R.H. Modulation of mesoprefrontal dopamine neurons by central benzodiazepine receptors. I. Pharmacological characterization. J. Pharmacol. Exp. Ther. 252:1990;989-996.
31. Thierry A.M., Tassin J.P., Blanc G., Glowinski J. Selective activation of mesocortical DA system by stress. Nature. 263:1976;242-244.
32. Tsukada H., Harada N., Nishiyama S., Ohba H., Sato K., Fukumoto D., Kakiuchi T. Ketamine decreased striatal [(11)C]raclopride binding with no alterations in static dopamine concentrations in the striatal extracellular fluid in the monkey brain: multiparametric PET studies combined with microdialysis analysis. Synapse. 37:2000;95-103.
33. Tsukada H., Nishiyama S., Kakiuchi T., Ohba H., Sato K., Harada N., Nakanishi S. Isoflurane anesthesia enhances the inhibitory effects of cocaine and GBR12909 on dopamine transporter: PET studies in combination with microdialysis in the monkey brain. Brain Res. 849:1999;85-96.
34. Tsukada H., Yamazaki S., Noda A., Inoue T., Matsuoka N., Kakiuchi T., Nishiyama S., Nishimura S. FK960 [N-(4-acetyl-1-piperazinyl)-p-fluorobenzamide monohydrate], a novel potential antidementia drug, restores the regional cerebral blood flow response abolished by scopolamine but not by HA-966: a positron emission tomography study with unanesthetized rhesus monkeys. Brain Res. 832:1999;118-123.
35. Watanabe M., Okada H., Shimizu K., Omura T., Yoshikawa E., Kosugi T., Mori S., Yamashita T. A high resolution animal PET scanner using compact PS-PMT detectors. IEEE Trans. Nucl. Sci. 44:1997;1277-1282.